Commendations & Commencements
Dr. Guillermo A. Arreaza-Rubín received the 2018 Artificial Pancreas Research Award from the Diabetes Technology Society in November. Arreaza-Rubín is a program director in the NIDDK Division of Diabetes, Endocrinology, and Metabolic Diseases, where he oversees academic and small business research on novel technologies for diabetes diagnosis, monitoring, and treatment, including artificial pancreas development.
Dr. Caroline C. Philpott was selected as a member of the Association of American Physicians. Philpott is chief of NIDDK’s Genetics and Metabolism Section in the Liver Diseases Branch, where her research focuses on the biology of iron use in human health and disease.
JDRF in December recognized several NIDDK employees for their work on the Special Statutory Funding Program for Type 1 Diabetes Research, commonly known as the Special Diabetes Program.
- Editor’s Note: Dr. Griffin P. Rodgers was named a 2018 Type 1 Diabetes Champion.
- Dr. Judith Fradkin, who recently retired from NIDDK, received a Legacy Award. Prior to her retirement, Fradkin was director of NIDDK’s Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM) and coordinated the planning and implementation of the Special Diabetes Program.
- Five NIDDK employees received Excellence Awards. They are Dr. Beena Akolkar, DEM senior advisor; Dr. Richard Farishian, Office of Scientific Program and Policy Analysis (OSPPA) advisor; and Dr. Rebecca Cerio, Dr. Mary C. Hanlon-Tilghman, and Dr. Julie A. Wallace, all OSPPA health science policy analysts.
Welcome
Jayanthi Regunathan joined NIDDK in January as a senior grants management specialist. She previously worked as a senior grants management specialist at the National Heart, Lung, and Blood Institute.
Dr. Anna Sadusky joined NIDDK in March as a program director in the Division of Kidney, Urologic, and Hematologic Diseases overseeing research in the kidney and urology research portfolios, including projects on kidney injury and repair. Sadusky was previously director for regulatory science and policy at the American Association for Cancer Research and a senior scientist at the Omeros Corp. Previously, she was a postdoctoral fellow in the NIDDK Laboratory of Cellular and Developmental Biology.